Primary Area of Interest

• Genitourinary/Bladder Cancer
• Specific Area of Interest for this RFP:
  • It is not the intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
  • Projects considered for grant support will focus on one or more of the following:
    • Emerging data in NMIBC and implications on the current treatment paradigm, including the burden and impact of disease recurrence, complications resulting from current treatment algorithms and the resulting unmet needs for this patient population.
    • Management of patients with HR NMIBC, including but not limited to, identification and selection of appropriate patients related to emerging data in NMIBC, based on clinical risk stratification
    • Leveraging best practices for safe and effective integration of new immunotherapy therapies in NMIBC with a focus on urology and medical oncology shared decision-making

Funding Information

• Individual projects requesting up to $50,000-$200,000 will be considered. A total of $500,000 will be available for funding multiple projects.

Duration

• Maximum project length is 18-24 months.

Geographic Scope 

• United States

Target Audience 

• Urologists, uro-oncologists, medical oncologists, Advanced Practitioners (APPs/PA/NPs), nurses, and other healthcare professionals on the multidisciplinary care team responsible for the treatment of patients with NMIBC, in community and academic center settings.

Eligibility Criteria

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
• If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role, and the requesting organization must have a key role in the project.
• The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
• The project/program lead must be an employee or contractor of the requesting organization.
• Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
• For projects offering continuing education credit, the requesting organization must be accredited.

For more information, visit Pfizer.

https://cdn.pfizer.com/pfizercom/2025-07/2025-ONC-US-NMIBC-UnmetNeeds-IME.pdf?VersionId=3Ct_Biwgpgv4sLRNpXotp.07rcrdu.QS